PMC:7195088 / 31118-31234
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T34","span":{"begin":38,"end":46},"obj":"Body_part"},{"id":"T35","span":{"begin":101,"end":103},"obj":"Body_part"}],"attributes":[{"id":"A34","pred":"fma_id","subj":"T34","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A35","pred":"fma_id","subj":"T35","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"Tocilizumab Humanized monoclonal IgG1 antibody, tocilizumab inhibits both membrane-bound and soluble IL-6 receptors."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T172","span":{"begin":12,"end":21},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T173","span":{"begin":74,"end":82},"obj":"http://purl.obolibrary.org/obo/UBERON_0000158"}],"text":"Tocilizumab Humanized monoclonal IgG1 antibody, tocilizumab inhibits both membrane-bound and soluble IL-6 receptors."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T418","span":{"begin":48,"end":59},"obj":"Chemical"},{"id":"T419","span":{"begin":101,"end":103},"obj":"Chemical"}],"attributes":[{"id":"A418","pred":"chebi_id","subj":"T418","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"},{"id":"A419","pred":"chebi_id","subj":"T419","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A420","pred":"chebi_id","subj":"T419","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"}],"text":"Tocilizumab Humanized monoclonal IgG1 antibody, tocilizumab inhibits both membrane-bound and soluble IL-6 receptors."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T244","span":{"begin":0,"end":116},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Tocilizumab Humanized monoclonal IgG1 antibody, tocilizumab inhibits both membrane-bound and soluble IL-6 receptors."}